Name
Cogent Biosciences
Company Description
Cogent Biosciences is dedicated to advancing precision therapies for patients with unmet medical needs. Our lead program, bezuclastinib, is in development for Systemic Mastocytosis and Gastrointestinal Stromal Tumors. Beyond this, our early-stage pipeline includes novel therapies targeting FGFR2, ErbB2, PI3Kα and KRAS. With headquarters in Waltham, MA, and Boulder, CO, we are committed to scientific innovation and improving patient outcomes. Learn more at www.cogentbio.com.
Website
Product Categories (7)
Hematologic Cancers, Sarcoma/Bone and Soft Tissue Cancers, Biotechnology, Pharmaceutical
Featured Exhibitor
Yes
Address
Waltham, MA
United States
United States
Badges
